IP Library Granted Patent US 10,600,513
Granted Patent B2
US 10,600,513 · App. 16/103,001 · Granted Mar 24, 2020

Medication tracking

Inventors: Jennifer Ashley Gitchell (Washington, DC); Timothy James Leo Kress-Spatz (Washington, DC); Kevin William MacDonald (Washington, DC); Nicholas Bastien Petersen (Washington, DC); Julie Christina Meloni (Washington, DC); Christian Lee Doyle (Silver Spring, MD); Michael David Waud (Washington, DC); David Mario Pedra (Washington, DC); Nicholas Ward Stocchero (Washington, DC); Michael Christopher Wimpee (Washington, DC); Steven Shyu (Washington, DC); Mahesh Murali (Washington, DC)
Assignee: Kit Check, Inc.
G16H40/20A61J1/00A61J1/18G06F19/00G06K7/10366G06Q10/087G06Q50/22A61G12/001A61J2205/30A61J2205/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,600,513
App. No.
16/103,001
Granted
Mar 24, 2020
Kind
B2
Abstract

A system and method is described for printing a label with an RFID tag. The system includes an RFID reader that queries a first RFID tag coupled to a first medicinal container that includes a medication. In response, the system receives a first unique identifier and uses the first unique identifier to determine a status of the medication, associate the first medicinal container with a medical provider and print a second label that includes a second RFID tag for a second medicinal container.

Claims (49)

1. A system comprising:

an RFID reader configured to query an RFID tag of a label coupled to a medicinal container associated with a drug and receive a unique identifier from the RFID tag, wherein the unique identifier uniquely identifies the medicinal container from other medicinal containers, wherein the label comprises a transparent portion including an adhesive, an RFID portion that includes the RFID tag, a first opaque portion comprising an adhesive and a second opaque portion comprising an adhesive, wherein a length of the transparent portion extends along a length of the RFID portion wherein the first opaque portion and the second opaque portion are detachably coupled to the RFID portion; and

a computing device coupled to the RFID reader and configured to:

receive the unique identifier,

query a remotely located database for drug data of the drug using the unique identifier,

receive drug usage information based at least in part on user input,

determine a drug expiration date of the drug, wherein to determine the drug expiration date, the computing device is configured to:

determine a first expiration date based at least in part on the drug data, wherein the first expiration date corresponds to at least one of an expiration based at least in part on a sealed seal, an expiration based at least in part on refrigeration, or an expiration based at least in part on a vial expiration,

determine a second expiration date based at least in part on the drug usage information, wherein the second expiration date corresponds to at least one of an expiration based at least in part on a broken seal, an expiration based at least in part on non-refrigeration, or an expiration based at least in part on a syringe expiration, and

identify the drug expiration date as the earlier of the first expiration date and the second expiration date, and

update the drug data of the remotely located database to associate the drug expiration date with the unique identifier and mark the drug as at least one of an opened drug, an un-refrigerated drug, or a syringe drug.

2. A system comprising:

an RFID reader configured to query an RFID tag of a label coupled to a medicinal container and receive a unique identifier from the RFID tag; and

a computing device coupled to the RFID reader and configured to:

receive the unique identifier,

query, based at least in part on receipt of the unique identifier, a remotely located database for drug data of a drug associated with the medicinal container,

receive drug usage information,

determine a drug expiration date of the drug, wherein to determine the drug expiration date, the computing device is configured to:

determine a first expiration date based at least in part on the drug data,

determine a second expiration date based at least in part on the drug usage information, and

identify the drug expiration date as the earlier of the first expiration date and the second expiration date, and

update the drug data of the remotely located database to associate the drug expiration date with the unique identifier.

3. The system of claim 2 , wherein the drug data indicates that the drug is at least one of a multi-dose drug, a drug for refrigeration, or a liquid drug, wherein the medicinal container for a multi-dose drug comprises a seal, wherein the medicinal container for a liquid drug comprises at least one of a vial or a syringe.

4. The system of claim 2 , wherein the drug is a multi-dose drug, the medicinal container comprises a seal, the first expiration date corresponds to an expiration based at least in part on a sealed seal, and the second expiration date corresponds to an expiration based at least in part on a broken seal.

5. The system of claim 4 , wherein the drug usage information comprises at least one of an indication that the seal is broken, an indication that the seal is punctured, an indication of a date that the seal was broken, or an indication of a date that the seal was punctured.

6. The system of claim 2 , wherein the drug is a drug for refrigeration, the first expiration date corresponds to an expiration based at least in part on refrigeration, and the second expiration date corresponds to an expiration that is different from the first expiration date and is based at least in part on non-refrigeration.

7. The system of claim 6 , wherein the drug usage information comprises at least one of an indication that the drug for refrigeration is un-refrigerated, an indication of a duration of time that the drug for refrigeration was un-refrigerated, or an indication of a date that the drug for refrigeration was un-refrigerated.

8. The system of claim 2 , wherein the drug is a fluid, the medicinal container comprises at least one of a vial or a syringe, the first expiration date corresponds to an expiration based at least in part on a vial expiration, and the second expiration date corresponds to an expiration based at least in part on a syringe expiration.

9. The system of claim 8 , wherein the drug usage information comprises at least one of an indication that the drug is contained in the syringe or an indication of a date that the drug was transferred to the syringe.

10. The system of claim 2 , wherein the drug data comprises a drug name, concentration, and total amount of the drug in the medicinal container.

11. The system of claim 2 , wherein the label comprises a transparent portion including an adhesive, an RFID portion that includes the RFID tag and does not include an adhesive, a first opaque portion comprising an adhesive and a second opaque portion comprising an adhesive, wherein a length of the transparent portion extends along a length of the RFID portion and at least a portion of the drug data is printed onto the RFID portion, and a name of the drug is printed on the first opaque portion and the second opaque portion, and wherein the first opaque portion and the second opaque portion are detachably coupled to the RFID portion.

12. The system of claim 2 , wherein the computing device is further configured to generate a notification that the drug is expired based at least in part on the drug expiration date.

13. A method comprising:

querying an RFID tag of a label coupled to a medicinal container;

receiving a unique identifier from the RFID tag, wherein the unique identifier uniquely identifies the medicinal container from other medicinal containers in a pharmaceutical item storage unit;

querying, based at least in part on receiving the unique identifier, a remotely located database for medication data of a medication associated with the medicinal container;

receiving medication usage information;

determining a medication expiration date of the medication, wherein said determining the medication expiration date comprises:

determining a first expiration date based at least in part on the medication data,

determining a second expiration date based at least in part on the medication usage information, and

identifying the medication expiration date, wherein the medication expiration date is the earlier of the first expiration date and the second expiration date; and

updating the medication data of the remotely located database to associate the medication expiration date with the unique identifier.

14. The method of claim 13 , wherein the medication data indicates that the medication is at least one of a multi-dose drug, a medication for refrigeration, or a liquid medication, wherein the medicinal container for a multi-dose drug comprises a seal, wherein the medicinal container for a liquid medication comprises at least one of a vial or a syringe.

15. The method of claim 13 , wherein the medication is a multi-dose drug, the medicinal container comprises a seal, the first expiration date corresponds to an expiration based at least in part on a sealed seal, and the second expiration date corresponds to an expiration based at least in part on a broken seal.

16. The method of claim 15 , wherein the medication usage information comprises at least one of an indication that the seal is broken, an indication that the seal is punctured, an indication of a date that the seal was broken, or an indication of a date that the seal was punctured.

17. The method of claim 13 , wherein the medication is a medication for refrigeration, and the first expiration date corresponds to an expiration based on refrigeration, and the second expiration date corresponds to an expiration date that is different from the first expiration date and is based at least in part on non-refrigeration.

18. The method of claim 17 , wherein the medication usage information comprises at least one of an indication that the medication for refrigeration is un-refrigerated, an indication of a duration of time that the medication for refrigeration was un-refrigerated, or an indication of a date that the medication for refrigeration was un-refrigerated.

19. The method of claim 13 , wherein the medication is a fluid, the medicinal container for comprises at least one of a vial or a syringe, the first expiration date corresponds to an expiration based at least in part on a vial expiration, and the second expiration date corresponds to an expiration based at least in part on a syringe expiration.

20. The method of claim 19 , wherein the medication usage information comprises at least one of an indication that the medication is contained in the syringe or an indication of a date that the medication was transferred to the syringe.

Assignments (8)
RELEASE OF SECURITY INTEREST AT R/F 46235/0172 Recorded Jul 18, 2023
From: ORIX GROWTH CAPITAL, LLC
To: BLUESIGHT, INC. (F/K/A KIT CHECK, INC.)
Reel/Frame 064309/0352 →
RELEASE OF SECURITY INTEREST Recorded Jul 18, 2023
From: WESTERN ALLIANCE BANK
To: BLUESIGHT, INC. (F/K/A KIT CHECK, INC.)
Reel/Frame 064303/0585 →
SECURITY INTEREST Recorded Jul 17, 2023
From: BLUESIGHT, INC.
To: MONROE CAPITAL MANAGEMENT ADVISORS, LLC, AS COLLATERAL AGENT
Reel/Frame 064284/0736 →
CHANGE OF NAME Recorded Feb 16, 2023
From: KIT CHECK, INC.
To: BLUESIGHT, INC.
Reel/Frame 062775/0703 →
SECURITY INTEREST Recorded Nov 4, 2021
From: KIT CHECK, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 058018/0443 →
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2021
From: SILICON VALLEY BANK
To: KIT CHECK, INC.
Reel/Frame 057789/0706 →
SECURITY INTEREST Recorded Jul 3, 2019
From: KIT CHECK, INC.
To: SILICON VALLEY BANK
Reel/Frame 049662/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: GITCHELL, JENNIFER ASHLEY; KRESS-SPATZ, TIMOTHY JAMES LEO; MACDONALD, KEVIN WILLIAM; PETERSEN, NICHOLAS BASTIEN; MELONI, JULIE CHRISTINA; DOYLE, CHRISTIAN LEE; WAUD, MICHAEL DAVID; PEDRA, DAVID MARIO; STOCCHERO, NICHOLAS WARD; WIMPEE, MICHAEL CHRISTOPHER; SHYU, STEVEN; MURALI, MAHESH
To: KIT CHECK, INC.
Reel/Frame 046645/0623 →
Continuity (8)
Continuation 15426302 · Feb 7, 2017
Continuation 14876533 · Oct 6, 2015
Continuation 14563732 · Dec 8, 2014
Provisional Application 62062845 · Oct 11, 2014
Provisional Application 62020576 · Jul 3, 2014
Provisional Application 62000570 · May 20, 2014
Provisional Application 61913337 · Dec 8, 2013
Related Publication 20190115098A1 · Apr 18, 2019
Cited By (5)
US 12,400,746 US 12,443,920 US 12,494,283 US 12,626,817 US 12,712,059